Moderna and Merck's vaccine, with Keytruda, has shown promising results in preventing the recurrence of severe skin cancer for three years, according to a study. Meanwhile, China has detected seven people infected with the new COVID variant JN.1, prompting the WHO to classify it as a 'Variant of Interest' due to its rapidly increasing spread. The variant is raising concerns about a potential new wave of disease across the U.S. as other respiratory viruses are also surging.
Rapidly spreading COVID variant given new distinction by World Health Organization https://t.co/gJ15Nvpvru
The World Health Organisation (WHO) has classified the JN.1 COVID strain as a "variant of interest" https://t.co/iGt55cFRcj
A fast-spreading new COVID-19 variant called JN.1 could drive a new wave of disease across the U.S. this holiday season just as other respiratory viruses are cresting, experts say. https://t.co/KFNe1vq9cL
19 more sequences of JN.1 covid variant found https://t.co/AolduuSNt0
Rapidly spreading COVID variant given new distinction by World Health Organization https://t.co/gEHFuiQFpl
5 things to know about the new COVID variant of interest, JN.1 https://t.co/7RizP1fIu3
5 things to know about the new COVID variant of interest, JN.1 https://t.co/ER2IUyrMDx
JUST IN - WHO classifies JN.1 COVID variant as a 'Variant of Interest' due to 'rapidly increasing spread'
5 things to know about the new COVID variant of interest, JN.1 https://t.co/lnT9j47sif https://t.co/MWPHsqIV0r
WHO classifies COVID variant JN.1 as a Variant of Interest due to "rapidly increasing spread" https://t.co/jPNWvcTjCf
Temporal changes to adult case fatality risk of COVID-19 after vaccination in England between May 2020 and February 2022: a national surveillance study Do vaccines reduce the case fatality rate compared with those not vaccinated? Of course they do! https://t.co/M1Axm0MYlS 1/3
It’s been three years since the Covid vaccine was released to the public. Since then, we’ve been told a variety of – sometimes conflicting – things: https://t.co/4u2xB7QzDh By @FlorioGina https://t.co/vVddnYpwTy
The Centre issued advisory to states amid recent upsurge in Covid-19 cases in some states and detection of first case of JN.1 variant in the country. Read more: https://t.co/Uu3ZilAhHr https://t.co/XurM9eVwD7
There's plenty going on in the world of Covid. Here's an update that includes the JN.1 variant, US status, the booster, #LongCovid, new inhalation vaccine data, and my bout. In a new Ground Truths (see profile) https://t.co/yXA1e0q9c1
Moderna: good news on skin cancer vaccine is welcome distraction from Covid-19 shot sales woes https://t.co/mLX7kvIY1U | opinion
#CHINA DETECTS SEVEN INFECTIONS OF #COVID JN.1 VARIANT
CHINA DETECTS 7 PEOPLE INFECTED WITH NEW COVID VARIANT JN.1
$MRNA (+11.1% pre) Moderna, $MRK Merck vaccine with Keytruda delays return of deadly skin cancer after 3 years, data says - CNBC https://t.co/Cl7hzbaUpx
A personalized vaccine developed by Merck and Moderna helped prevent the recurrence of severe skin cancer for three years, in promising new results from a study https://t.co/jVYbDmkbsC